NCT01524380View on ClinicalTrials.gov

Ginkgo Biloba Extract for Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

August 31, 2013

Conditions
Schizophrenia
Interventions
DRUG

Ginkgo biloba extract

400mg/day, twice a day, 10 weeks

DRUG

Placebo

twice a day, 10 weeks

Trial Locations (1)

100096

Beijing HuiLongGuan Hospital, Beijing

All Listed Sponsors
lead

Beijing HuiLongGuan Hospital

OTHER

NCT01524380 - Ginkgo Biloba Extract for Schizophrenia | Biotech Hunter | Biotech Hunter